| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Patrick P Grace is Director at CHE and has filed Form 4s across 2 companies. Patrick P Grace's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $1.9M at current prices.
Historically, Patrick P Grace's trades have earned a below-average insider score of 46/100 across 7 rated trades. Over a 12-month horizon, 20.0% of those trades were profitable, with an average 12-month return of -6.0%.
The biggest single holding is CHE (~$1.9M) as Director. The CHE filings lean toward selling, a net 4,946 shares.
Patrick P Grace has 30 Form 4 filings on record from May 2015 to July 2026, across 2 companies: Director at Chemed (CHE), 2015–2026; Director at Tonix Pharmaceuticals (TNXP), 2016–2019.
The 34 reported transactions were 16 open-market sales, 12 stock awards, 3 option or other derivative awards and 3 option exercises.
Counted by filing, the open-market trades come to no purchases and 14 sales worth about $1.9M.
The largest open-market sale was 1,520 shares of CHE at an average $450.18 on June 18, 2020, about $684K.
None of the 5 sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 31, 2026 | CHE Chemed Corporation | Director | Sell | 190 | $532.00 | $101,080.00 | -5.1% | +1.8% | - | |
| May 8, 2026 | CHE Chemed Corporation | Director | Sell | 60 | $425.78 | $25,546.80 | -1.8% | +29.5% | - | |
| Sep 9, 2025 | CHE Chemed Corp | Director | Sell | 150 | $463.39 | $69,508.50 | -4.2% | -10.9% | +12.1% | |
| Jun 12, 2024 | CHE Chemed Corp | Director | Sell | 284 | $540.98 | $153,638.32 | -8.0% | +5.9% | +3.1% | |
| May 26, 2023 | CHE Chemed Corp | Director | Sell | 294 | $544.24 | $160,006.56 | -8.2% | -7.7% | +2.5% | |
| Jun 10, 2022 | CHE Chemed Corp | Director | Sell | 262 | $465.47 | $121,953.14 | -7.4% | +2.0% | +14.9% | |
| Nov 5, 2021 | CHE Chemed Corp | Director | Sell | 279 | $494.28 | $137,904.12 | -7.9% | -5.5% | -2.8% | |
| Jun 18, 2020 | CHE Chemed Corp | Director | Sell | 1,520 | $450.18 | $684,266.80 | -31.7% | - | - | |
| Aug 7, 2019 | CHE Chemed Corp | Director | Sell | 257 | $415.43 | $106,765.51 | -5.4% | - | - | |
| Jun 22, 2018 | CHE Chemed Corp | Director | Sell | 250 | $323.76 | $80,940.00 | -5.2% | - | - |